Encouraging study on hemophilia
A preliminary study of gene therapy for hemophilia indicates that the treatment appears safe and that the added genes can function for months. The study, described in the The New England Journal of
A preliminary study of gene therapy for hemophilia indicates that the treatment appears safe and that the added genes can function for months. The study, described in the The New England Journal of